Michael King - CHIEF FINANCIAL OFFICER at SAB Biotherapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
SABS, SABSW on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Michael King since 12/22/2023

Holdings reported by Michael King for SAB Biotherapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 5K $4.4K $0.88 Nov 30, 2023 Direct
Employee Stock Option (right to buy) 115K Feb 21, 2024 Direct Common Stock

Transactions reported by Michael King for SAB Biotherapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.